Thus, the accumulation of M2 macrophages could contribute to the development of an immunosuppressive tumor microenvironment that promotes tumor cell growth, and targeting IL-10–induced M2 macrophage polarization might be a potential therapeutic approach for AITL. Here, IL10 is linked to angioimmunoblastic T-cell lymphoma.